Tag: phase 2 trial
New Drug Shows Promise for Rare Gastrointestinal Tumors in Phase 2 Trial
A phase 2 trial shows rogaratinib, an FGFR inhibitor, demonstrates encouraging efficacy in patients with SDH-deficient GIST. The study represents…
New Pancreatic Cancer Drug Daraxonrasib Shows Promise in Phase 2 Trial
A phase 2 trial published in NEJM shows promise for daraxonrasib, a novel targeted therapy for previously treated metastatic pancreatic…
Savolitinib Shows Promise for MET-Amplified Gastric Cancer in Phase 2 Trial
A phase 2 trial shows promising clinical efficacy for savolitinib in treating patients with MET-amplified gastric or gastroesophageal junction adenocarcinoma.…
Submit Your Paper to GMJ
No APC until January 2027.